Theranostics and radiopharmaceutical therapies are rapidly transforming the medical landscape, and the neuro-oncology community is observing these developments with great interest. In a field characte ...
Irène Buvat, PhD, Centre National de la Recherche Scientifique director of research and head of the Inserm Laboratory of Translational Imaging in Oncology at the Institut Curie, Orsay (France), and ...
See an invited perspective on this article on page 1412. Tumor growth and spread are determined not only by cancer cells but also by the nonmalignant constituents of the malignant lesion, which are ...
Journal of Nuclear Medicine July 2025, jnumed.125.270167; DOI: https://doi.org/10.2967/jnumed.125.270167 ...
The aim of this study was to evaluate the physical performance of the Vereos whole-body PET/CT system according to the National Electrical Manufacturers Association (NEMA) NU2-2012 standard and to ...
Journal of Nuclear Medicine October 2025, jnumed.125.270804; DOI: https://doi.org/10.2967/jnumed.125.270804 ...
Journal of Nuclear Medicine October 2025, jnumed.125.270825; DOI: https://doi.org/10.2967/jnumed.125.270825 ...
This paper presents standardized methods for performing dose calculations for radiopharmaceuticals. Various steps in the process are outlined, with some specific examples given. Special models for ...
Osteosarcoma is a malignant bone tumor with very limited therapeutic options ( [ 1 ] [1]). However, targeting the frequently overexpressed disialoganglioside GD2 was successful in preclinical studies ...
Despite significant advancements in medical and device-based therapies, cardiovascular disease remains the number one cause of death in the United States. Early detection of atherosclerosis, ...
The development of novel multimodality imaging agents and techniques represents the current frontier of research in the field of medical imaging science. However, the combination of nuclear tomography ...
First-in-Human PET Imaging of MT1-MMP in a Patient with Breast and Muscle-Invasive Urothelial Bladder Cancer Using the Bicyclic Radiotracer [68 Ga]Ga-BCY25286 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback